Impact of Intravenous Iron on Musculoskeletal Function in Older Adults

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2023

Primary Completion Date

August 31, 2026

Study Completion Date

January 31, 2027

Conditions
Iron Deficiency Anemia
Interventions
DRUG

Ferinject

"Ferinject Therapy Group: each patient's Iron need for repletion by the Ferinject will be determined using product SPC dosing based on patient's body weight and Hb level. Accordingly, the appropriate dose of Ferinject will be administered while ensuring that a single administration will not exceed:~* 15 mg iron/kg body weight (for administration by intravenous injection) or 20 mg iron/kg body weight (for administration by intravenous infusion)~* 1,000 mg of iron (20 mL Ferinject) The cumulative dose of Ferinject per week will not exceed 1,000 mg of iron (20 mL Ferinject)."

DRUG

Ferrous Sulfate 200 MG

Active Control Group (standard care excl. IV Iron): Oral Ferrous sulphate 200 mg three times daily.

All Listed Sponsors
collaborator

Liverpool University Hospitals NHS Foundation Trust

OTHER_GOV

lead

Liverpool Hope University

OTHER